SCHEMBL7095693

SCHEMBL7095693

CC(C)C(C)(Nc1ccccc1[N+](=O)[O-])C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
MAPK1 P28482 3/20 0.51
TDP1 Q9NUW8 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
NPSR1 Q6W5P4 3/20 0.51
PDK1 Q15118 1/20 0.49
PDK2 Q15119 1/20 0.49
PDK3 Q15120 1/20 0.49
PDK4 Q16654 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 3/20 0.46
CASP7 P55210 1/20 0.46
POLB P06746 2/20 0.45
GAA P10253 2/20 0.45
RAB9A P51151 5/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPC1 O15118 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11657337 0.82 PDK1 (0.54) MAPTMAPK1TDP1L3MBTL1NPSR1
SCHEMBL24187914 0.77 PDK1 (0.55) MAPTMAPK1TDP1L3MBTL1NPSR1
SCHEMBL4867823 0.77 KMT2A (0.51) MAPTMAPK1TDP1L3MBTL1NPSR1
SCHEMBL677655 0.76 MAPK1 (0.55) MAPTMAPK1TDP1L3MBTL1NPSR1
SCHEMBL13729342 0.75 KMT2A (0.53) MAPTMAPK1TDP1L3MBTL1NPSR1
SCHEMBL2312212 0.74 NPSR1 (0.50) MAPTMAPK1TDP1L3MBTL1NPSR1
SCHEMBL10359712 0.74 MAPK1 (0.53) MAPTMAPK1TDP1L3MBTL1NPSR1
SCHEMBL24202393 0.74 NPSR1 (0.47) MAPTNPSR1PDK1PDK2PDK3
SCHEMBL23123715 0.74 NPSR1 (0.60) MAPTMAPK1TDP1L3MBTL1NPSR1
SCHEMBL8758916 0.74 RAB9A (0.46) MAPTTDP1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337550-A2 HEPATITIS C TRIPEPTIDE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-08-27 EP disclosed
WO-2002060926-A2 HEPATITIS C TRIPEPTIDE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-08-08 WO disclosed